Sigma-Aldrich Investor Relations Sigma-Aldrich Investor Home Home Sigma-Aldrich home page



Committee Composition

Chair of the Board = Chair of the Board Committee Chair = Chair Committee Member = Member
  Audit Corporate Governance Compensation Science & Technology
Rebecca M. Bergman Member of Audit Committee     Member of Science & Technology Committee
George M. Church, Ph. D.   Member of Corporate Governance Committee   Member of Science & Technology Committee
Michael L. Marberry Member of Audit Committee   Committee Chair for Compensation Committee  
W. Lee McCollum Member of Audit Committee Committee Chair for Corporate Governance Committee    
Avi M. Nash Committee Chair for Audit Committee   Member of Compensation Committee  
Steven M. Paul, M.D.     Member of Compensation Committee Committee Chair for Science & Technology Committee
Director of the Appel Alzheimer's Disease Research Institute and Professor of Neurology, Psychiatry and Pharmacology at Weill Cornell Medical College

Dr. Paul is currently the Director of the Appel Alzheimer’s Disease Research Institute and a Professor of Neurology (Neuroscience), Psychiatry and Pharmacology at Weill Cornell Medical College of Cornell University.  He has more than 20 years of management experience in the pharmaceutical and biotechnology industries and 37 years of scientific research experience.  Dr. Paul retired in 2010 as Executive Vice President for Science and Technology and President of the Lilly Research Laboratories of Eli Lilly and Company (“Lilly”), a pharmaceutical company that engages in the discovery, development, manufacture and sale of pharmaceutical products, positions he held since 2003.  He joined Lilly in 1993 and served in roles of increasing responsibility within the Lilly research organization, including Vice President of Discovery Research and Clinical Investigation.  Prior to joining Lilly, Dr. Paul served in several senior roles at the National Institute of Mental Health, including serving as the Scientific Director of the Intramural Research Program.  He has authored or coauthored more than 500 papers and invited book chapters and serves on the editorial boards of numerous scientific journals and as a grant reviewer for several extramural and intramural committees.  He is a director of Alnylam Pharmaceuticals and a Venture Partner at Third Rock Ventures.  He is also a director of the Foundation of the National Institutes of Health, a member of the Institute of Medicine of the National Academy of Sciences and a Fellow of the American Association for the Advancement of Science.  Dr. Paul holds M.D., M.S. and B.A. degrees from Tulane University.  Age 63.


J. Pedro Reinhard   Member of Corporate Governance Committee Member of Compensation Committee  
Rakesh Sachdev        
D. Dean Spatz   Member of Corporate Governance Committee   Member of Science & Technology Committee
Barrett Toan Chairman of the Board   Member of Corporate Governance Committee    

 

© 2014 Sigma-Aldrich Co. Reproduction forbidden without permission.
Sigma-Aldrich brand products are sold exclusively through Sigma-Aldrich, Inc. Best viewed in IE5 or higher